On Tuesday, Avid Bioservices Inc (CDMO) stock saw a decline, ending the day at $12.23 which represents a decrease of $-0.02 or -0.16% from the prior close of $12.25. The stock opened at $12.25 and ...

Private equity investors GHO Capital Partners and Ampersand Capital Partners have announced a merger agreement for the ...

Avid Bioservices Chief Executive Nick Green said the company’s board considered several options before determining to move ...

We are bullish on Avid's potential take-private deal by Ampersand and GHO, predicting value creation and optimistic about ...

Just days after laying out $90 million to acquire Nektar Therapeutics’ Alabama manufacturing plant, Ampersand Capital ...

Avid Bioservices (NASDAQ:CDMO) has agreed to be acquired by funds managed by GHO Capital Partners and Ampersand Capital Partners through a cash deal that values the company at around $1.1B. Under the ...

Avid Bioservices shares were up 12% at $12.25 after getting a buyout offer from GHO Capital Partners and Ampersand Capital Partners. Under the terms of the buyout, Avid will be acquired by funds ...

Avid Bioservices Inc., a Tustin-based biotech company, agreed to go private in an $850-million deal that values the company ...

Avid Bioservices ( (CDMO) ) just unveiled an announcement. Avid Bioservices, a biologics contract development and manufacturing organization, is set to be acquired by GHO Capital Partners and ...

The definitive merger agreement stipulates that GHO and Ampersand will purchase all outstanding shares of Avid.

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Avid Bioservices, Inc. (NASDAQ: CDMO) to ...

The $12.50-per-share takeover has been approved by Avid's board and is scheduled to close in the first quarter of 2025, ...